Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer
Clinical trial NCT02646358 · COMPLETED
Trial details
- NCT number
- NCT02646358
- Sponsor
- Mast Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-11-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.